BridgeBio Pharma LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
BridgeBio Pharma LLC
CIK #0001743881, 0002076615
EDGAR Form CIK 2011 - 2025
10-K [0001743881]
10-Q [0001743881]
3 [0001743881]
4 [0001743881]
5 [0001743881]
8-K [0001743881]
SC 13D [0001743881]
SC 13G [0001743881]
3 [0002076615]
SC 13D [0002076615]
Form 13D/13G Filer Form 13D/13G Subject Filed
Bridgebio Pharma LLC Bridgebio Oncology Therapeutics Inc [2025-08-18]
State Street Corp Bridgebio Pharma Inc [2023-02-08]
Vanguard Group Inc Bridgebio Pharma Inc [2021-02-10]
BlackRock Inc Bridgebio Pharma Inc [2021-02-05]
Eidos Therapeutics Inc Bridgebio Pharma Inc [2020-10-15]
American International Group Inc Bridgebio Pharma Inc [2020-02-14]
Kumar Neil Bridgebio Pharma Inc [2020-02-14]
Perceptive Advisors LLC Bridgebio Pharma Inc [2019-07-11]
KKR Genetic Disorder LP Bridgebio Pharma Inc [2019-07-10]
Viking Global Investors LP Bridgebio Pharma Inc [2019-07-08]
Bridgebio Pharma LLC Eidos Therapeutics Inc [2018-08-01]
Form 3/4/5 Subject 2011 - 2025
BridgeBio Pharma, Inc.
Apuli Maricel
Trimarchi Thomas
Kumar Neil
BridgeBio Pharma LLC
BridgeBio Oncology Therapeutics, Inc.
Homcy Charles J
Ellis Andrea
Viking Global Opportunities Portfolio GP LLC
Viking Global Opportunities Illiquid Investments Sub-Master
View All
Terms | Privacy | Guide
tony@aum13f.com